about
Population structure among mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in ColombiaCharacterization of extensively drug-resistant tuberculosis cases from Valle del Cauca, ColombiaGenotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary DiseaseMoxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence.Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates.Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia.Assessment of children exposed to adult pulmonary tuberculosis in Cali, Colombia.High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public–private initiative: Table 1–Risk of infection and disease progression in children exposed to tuberculosis at home, Colombia
P50
Q28659843-6CD6AE8C-A111-4AAF-B419-D13FB2CA0367Q28710571-5233A1B0-693D-428D-8B21-FCEEB43CFE4AQ36290565-AFAFC36B-2CE8-4506-B4DE-CE6207995111Q36571826-19F42FF6-2365-4356-A52A-AC6FA2D89C11Q36644647-262CD26A-7408-4F35-8D8F-C100C10ED907Q36887811-2F7C982F-95FC-4B91-93F1-B058DD125DC8Q36933441-BCF88EDA-C2E8-42AA-8926-F04C72F0C84CQ37287641-C02F30D1-EFDC-4BF8-A801-7A4CF5DD868AQ38152468-8AA49DB2-56FC-4628-ACF5-C385B6A39345Q38988324-EFFF3384-3216-4A60-B46C-0279B24034AFQ39108163-A1095731-F1BE-45E2-9BE1-19DE523B3521Q40093562-0EA4BBE4-10A7-40F0-B211-D85485AEBE95Q40133236-7A07962D-1928-48EF-988B-C5C4959B59EDQ41913843-2B1120CA-6867-4568-BC81-4630D79CF9B8Q44011119-5BC90AC0-814E-43DE-B7FE-E287AB06C85DQ58075909-C5699909-F106-4D9D-91A5-A0366840B32AQ96021753-F3E216A9-479A-4E35-A232-34B68BCE5037
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6045-1610
@en
name
Beatriz E Ferro
@ast
Beatriz E Ferro
@en
Beatriz E Ferro
@es
Beatriz E Ferro
@nl
type
label
Beatriz E Ferro
@ast
Beatriz E Ferro
@en
Beatriz E Ferro
@es
Beatriz E Ferro
@nl
prefLabel
Beatriz E Ferro
@ast
Beatriz E Ferro
@en
Beatriz E Ferro
@es
Beatriz E Ferro
@nl
P106
P1153
6602974111
P21
P31
P496
0000-0001-6045-1610